Anti-PD-1 Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066175
  • May 2021
  • Biotechnology
  • 126 Pages
The global Anti-PD-1 Antibody market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Anti-PD-1 Antibody market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Anti-PD-1 Antibody market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Anti-PD-1 Antibody market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Bio X Cell, Ono Pharmaceutical Co., Ltd, BioVision Inc., Thermo Fisher Scientific, Inc., Merck KGaA, InvivoGen, Chugai Pharmaceutical Co., Ltd, Bristol-Myers Squibb, Abcam Plc., Arcus Biosciences
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Anti-PD-1 Antibody market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Anti-PD-1 Antibody market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Anti-PD-1 Antibody market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Anti-PD-1 Antibody market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Anti-PD-1 Antibody Market:
The Anti-PD-1 Antibody market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Bio X Cell, Ono Pharmaceutical Co., Ltd, BioVision Inc., Thermo Fisher Scientific, Inc., Merck KGaA, InvivoGen, Chugai Pharmaceutical Co., Ltd, Bristol-Myers Squibb, Abcam Plc., Arcus Biosciences

Anti-PD-1 Antibody Market Segment Analysis:
by Type
Monoclonal
Polyclonal
Application
Immunohistochemistry-Paraffin
IHC-P
Immunocytochemistry
ICC
Western Blotting
Flow Cytometry
ELISA

Geographic Coverage for Anti-PD-1 Antibody Market:
The market research report on global Anti-PD-1 Antibody market offers complete analysis across various regions across the world. The Anti-PD-1 Antibody market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Anti-PD-1 Antibody market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Anti-PD-1 Antibody Market Value and Forecast
  • US
  • Canada
Europe Anti-PD-1 Antibody Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Anti-PD-1 Antibody Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Anti-PD-1 Antibody Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Anti-PD-1 Antibody Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Anti-PD-1 Antibody market report:
  • The report provides key trends of the global Anti-PD-1 Antibody market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Anti-PD-1 Antibody industry
  • The report covers all the recent developments of the Anti-PD-1 Antibody market and helps to provide current industry updates
  • The report covers a detailed look over the global Anti-PD-1 Antibody Industry and provides with significant actionable insights
  • The Anti-PD-1 Antibody market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Anti-PD-1 Antibody market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Anti-PD-1 Antibody market
  • Comprehensive analysis of the Anti-PD-1 Antibody market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Anti-PD-1 Antibody market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Anti-PD-1 Antibody market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Anti-PD-1 Antibody market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Anti-PD-1 Antibody market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Anti-PD-1 Antibody market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Bio X Cell
  • Ono Pharmaceutical Co., Ltd
  • BioVision Inc.
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • InvivoGen
  • Chugai Pharmaceutical Co., Ltd
  • Bristol-Myers Squibb
  • Abcam Plc.
  • Arcus Biosciences
  • Monoclonal
  • Polyclonal
  • Immunohistochemistry-Paraffin
  • IHC-P
  • Immunocytochemistry
  • ICC
  • Western Blotting
  • Flow Cytometry
  • ELISA

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Anti-PD-1 Antibody Market Snapshot
          2.1.1. Global Anti-PD-1 Antibody Market By Type,2019
               2.1.1.1.Monoclonal
               2.1.1.2.Polyclonal
          2.1.2. Global Anti-PD-1 Antibody Market By Application,2019
               2.1.2.1.Immunohistochemistry-Paraffin
               2.1.2.2.IHC-P
               2.1.2.3.Immunocytochemistry
               2.1.2.4.ICC
               2.1.2.5.Western Blotting
               2.1.2.6.Flow Cytometry
               2.1.2.7.ELISA
          2.1.3. Global Anti-PD-1 Antibody Market By End-use,2019
          2.1.4. Global Anti-PD-1 Antibody Market By Geography,2019

3. Global Anti-PD-1 Antibody Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Anti-PD-1 Antibody Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Anti-PD-1 Antibody Market Size (US$), By Type, 2018 – 2028

5. Global Anti-PD-1 Antibody Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Anti-PD-1 Antibody Market Size (US$), By Application, 2018 – 2028

6. Global Anti-PD-1 Antibody Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Anti-PD-1 Antibody Market Size (US$), By End-use, 2018 – 2028

7. Global Anti-PD-1 Antibody Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Anti-PD-1 Antibody Market Analysis, 2018 – 2028 
          7.2.1. North America Anti-PD-1 Antibody Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Anti-PD-1 Antibody Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Anti-PD-1 Antibody Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Anti-PD-1 Antibody Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Anti-PD-1 Antibody Market Analysis, 2018 – 2028 
          7.3.1.  Europe Anti-PD-1 Antibody Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Anti-PD-1 Antibody Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Anti-PD-1 Antibody Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Anti-PD-1 Antibody Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Anti-PD-1 Antibody Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Anti-PD-1 Antibody Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Anti-PD-1 Antibody Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Anti-PD-1 Antibody Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Anti-PD-1 Antibody Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Anti-PD-1 Antibody Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Anti-PD-1 Antibody Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Anti-PD-1 Antibody Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Anti-PD-1 Antibody Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Anti-PD-1 Antibody Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Anti-PD-1 Antibody Market Analysis, 2018 – 2028 
          7.6.1.  MEA Anti-PD-1 Antibody Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Anti-PD-1 Antibody Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Anti-PD-1 Antibody Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Anti-PD-1 Antibody Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Anti-PD-1 Antibody Providers
        8.4.1 Bio X Cell
                8.4.1.1 Business Description
                8.4.1.2 Bio X Cell Geographic Operations
                8.4.1.3 Bio X Cell Financial Information
                8.4.1.4 Bio X Cell Product Positions/Portfolio
                8.4.1.5 Bio X Cell Key Developments
        8.4.2 Ono Pharmaceutical Co., Ltd
                8.4.2.1 Business Description
                8.4.2.2 Ono Pharmaceutical Co., Ltd Geographic Operations
                8.4.2.3 Ono Pharmaceutical Co., Ltd Financial Information
                8.4.2.4 Ono Pharmaceutical Co., Ltd Product Positions/Portfolio
                8.4.2.5 Ono Pharmaceutical Co., Ltd Key Developments
        8.4.3 BioVision Inc.
                8.4.3.1 Business Description
                8.4.3.2 BioVision Inc. Geographic Operations
                8.4.3.3 BioVision Inc. Financial Information
                8.4.3.4 BioVision Inc. Product Positions/Portfolio
                8.4.3.5 BioVision Inc. Key Developments
        8.4.4 Thermo Fisher Scientific, Inc.
                8.4.4.1 Business Description
                8.4.4.2 Thermo Fisher Scientific, Inc. Geographic Operations
                8.4.4.3 Thermo Fisher Scientific, Inc. Financial Information
                8.4.4.4 Thermo Fisher Scientific, Inc. Product Positions/Portfolio
                8.4.4.5 Thermo Fisher Scientific, Inc. Key Developments
        8.4.5 Merck KGaA
                8.4.5.1 Business Description
                8.4.5.2 Merck KGaA Geographic Operations
                8.4.5.3 Merck KGaA Financial Information
                8.4.5.4 Merck KGaA Product Positions/Portfolio
                8.4.5.5 Merck KGaA Key Developments
        8.4.6 InvivoGen
                8.4.6.1 Business Description
                8.4.6.2 InvivoGen Geographic Operations
                8.4.6.3 InvivoGen Financial Information
                8.4.6.4 InvivoGen Product Positions/Portfolio
                8.4.6.5 InvivoGen Key Developments
        8.4.7 Chugai Pharmaceutical Co., Ltd
                8.4.7.1 Business Description
                8.4.7.2 Chugai Pharmaceutical Co., Ltd Geographic Operations
                8.4.7.3 Chugai Pharmaceutical Co., Ltd Financial Information
                8.4.7.4 Chugai Pharmaceutical Co., Ltd Product Positions/Portfolio
                8.4.7.5 Chugai Pharmaceutical Co., Ltd Key Developments
        8.4.8 Bristol-Myers Squibb
                8.4.8.1 Business Description
                8.4.8.2 Bristol-Myers Squibb Geographic Operations
                8.4.8.3 Bristol-Myers Squibb Financial Information
                8.4.8.4 Bristol-Myers Squibb Product Positions/Portfolio
                8.4.8.5 Bristol-Myers Squibb Key Developments
        8.4.9 Abcam Plc.
                8.4.9.1 Business Description
                8.4.9.2 Abcam Plc. Geographic Operations
                8.4.9.3 Abcam Plc. Financial Information
                8.4.9.4 Abcam Plc. Product Positions/Portfolio
                8.4.9.5 Abcam Plc. Key Developments
        8.4.10 Arcus Biosciences
                8.4.10.1 Business Description
                8.4.10.2 Arcus Biosciences Geographic Operations
                8.4.10.3 Arcus Biosciences Financial Information
                8.4.10.4 Arcus Biosciences Product Positions/Portfolio
                8.4.10.5 Arcus Biosciences Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Anti-PD-1 Antibody Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Anti-PD-1 Antibody Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Anti-PD-1 Antibody Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Anti-PD-1 Antibody Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Anti-PD-1 Antibody Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Anti-PD-1 Antibody Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Anti-PD-1 Antibody Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Anti-PD-1 Antibody Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Anti-PD-1 Antibody Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Anti-PD-1 Antibody Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Anti-PD-1 Antibody Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Anti-PD-1 Antibody Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Anti-PD-1 Antibody Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Anti-PD-1 Antibody Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Anti-PD-1 Antibody Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Anti-PD-1 Antibody Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Anti-PD-1 Antibody: Market Segmentation 
FIG. 2 Global Anti-PD-1 Antibody Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Anti-PD-1 Antibody Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Anti-PD-1 Antibody Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Anti-PD-1 Antibody Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Anti-PD-1 Antibody Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Anti-PD-1 Antibody Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Anti-PD-1 Antibody Providers, 2019
FIG. 11 Global Anti-PD-1 Antibody Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Anti-PD-1 Antibody Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Anti-PD-1 Antibody Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Anti-PD-1 Antibody Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Anti-PD-1 Antibody Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Anti-PD-1 Antibody Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Anti-PD-1 Antibody Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Anti-PD-1 Antibody Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Anti-PD-1 Antibody market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Anti-PD-1 Antibody Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Anti-PD-1 Antibody Market Value, By Segment1, 2018 – 2028
TABLE  North America Anti-PD-1 Antibody Market Value, By Segment2, 2018 – 2028
TABLE  North America Anti-PD-1 Antibody Market Value, By Country, 2018 – 2028
TABLE  Europe Anti-PD-1 Antibody Market Value, By Segment1, 2018 – 2028
TABLE  Europe Anti-PD-1 Antibody Market Value, By Segment2, 2018 – 2028
TABLE  Europe Anti-PD-1 Antibody Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Anti-PD-1 Antibody Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Anti-PD-1 Antibody Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Anti-PD-1 Antibody Market Value, By Country, 2018 – 2028
TABLE  Latin America Anti-PD-1 Antibody Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Anti-PD-1 Antibody Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Anti-PD-1 Antibody Market Value, By Country, 2018 – 2028
TABLE  MEA Anti-PD-1 Antibody Market Value, By Segment1, 2018 – 2028
TABLE  MEA Anti-PD-1 Antibody Market Value, By Segment2, 2018 – 2028
TABLE  MEA Anti-PD-1 Antibody Market Value, By Country, 2018 – 2028
TABLE  Bio X Cell: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ono Pharmaceutical Co., Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BioVision Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck KGaA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  InvivoGen: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Chugai Pharmaceutical Co., Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abcam Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Arcus Biosciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Anti-PD-1 Antibody Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Anti-PD-1 Antibody Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Anti-PD-1 Antibody Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Anti-PD-1 Antibody Market, By Geography, 2019 (US$ Mn)
FIG.  Global Anti-PD-1 Antibody Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Anti-PD-1 Antibody Providers, 2016
FIG.  Global Anti-PD-1 Antibody Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Polyclonal Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anti-PD-1 Antibody Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global IHC-P Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Immunocytochemistry Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global ICC Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Western Blotting Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Flow Cytometry Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global ELISA Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Anti-PD-1 Antibody Market Value, 2018 – 2028, (US$ Mn)